Is there a role for molecular markers predicting the best chemotherapy to use in lung cancer?
Article
Drs. Nate Pennell, Mary Pinder, and Jack West discuss trials presented at ASCO 2013 testing the potential value of molecular marker testing to select optimal chemo for advanced non-small cell lung cancer (NSCLC).
[powerpress]
